Trikafta is a Kit in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is .
| Product ID | 51167-106_12edff26-ed48-49e6-b1b8-887447e6eac3 |
| NDC | 51167-106 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Trikafta |
| Generic Name | Elexacaftor, Tezacaftor, And Ivacaftor |
| Dosage Form | Kit |
| Marketing Start Date | 2021-06-08 |
| Marketing Category | NDA / |
| Application Number | NDA212273 |
| Labeler Name | Vertex Pharmaceuticals Incorporated |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-06-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51167-106 | Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor |
| 51167-331 | Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRIKAFTA 88031776 not registered Live/Pending |
Vertex Pharmaceuticals Incorporated 2018-07-10 |
![]() TRIKAFTA 87924202 5938974 Live/Registered |
Vertex Pharmaceuticals Incorporated 2018-05-16 |
![]() TRIKAFTA 87893193 5938914 Live/Registered |
Vertex Pharmaceuticals Incorporated 2018-04-25 |